Displaying drugs 15001 - 15025 of 15375 in total
BMS-564929
BMS-564929 is an investigational therapeutic agent built to be a selective androgen receptor modulator (SARM). So far, it has been developed by Bristol-Myers Squibb for the symptomatic treatment of andropause.
Experimental
SD-0006
Investigational
Alphamethadol
Experimental
Illicit
4-Flourobenzenesulfonamide
Experimental
AL5424
Experimental
3-Amino-4-Oxybenzyl-2-Butanone
Experimental
Phenylacetaldehyde
Experimental
AL7089A
Experimental
Undecyl-Phosphinic Acid Butyl Ester
Experimental
Benzylamine
Experimental
4-(Hydroxymethyl)Benzamidine
Experimental
1,3-Dinitrobenzene
Experimental
3-Nitrophenylboronic Acid
Experimental
Para-Bromobenzyl Alcohol
Experimental
4-Fluorobenzylamine
Experimental
2,6-Difluorobenzenesulfonamide
Experimental
1-(2-Amidinophenyl)-3-(Phenoxyphenyl)Urea
Experimental
3-Iodo-Benzyl Alcohol
Experimental
Displaying drugs 15001 - 15025 of 15375 in total